It was Benjamin Franklin who said only two things in life are certain: death and taxes. Actually taxes are anything but certain, and what is definitely not certain is how people will respond to them.
Unintended consequences are the bane of those looking to develop innovative ways of raising money from taxes. Look no further than the UK government’s decision to introduce a system of local taxation in the 1980s known as the community charge, aka the poll tax. It led to over 200,000 people protesting in London’s Trafalgar Square in 1990. The riots that ensued precipitated the end of Mrs Thatcher’s time in office and her successor John Major scrapped the tax.
In our era the bedroom tax was very unpopular and was ditched, while as I write the contentious 5% tampon tax is about to be scrapped in a deal with the EU.
Yet more often than not we become habituated to the taxes we pay. The standard rate of VAT is 20%, which increased in 2011 from 17.5% – but I think none of us protested, and few probably even remember the increase. Over the years we have come to expect taxes to increase on “sin” products such as alcohol and cigarettes, but the evidence that such taxes reduce how much of them we consume is sparse.
With cigarettes what seems to have been more important is that through the bans in public places, smoking has gradually become an antisocial activity. Certainly having to be part of a group of furtive smokers outside an office in the cold is not appealing.
The sweet hereafter
So what of the sugar tax? A day after the Budget it is difficult to say what impact it will have but let’s be clear, the likes of Jamie Oliver think it will be the start of reducing childhood obesity. I would be less sure. One only needs to look to Denmark – which attempted to introduce a fat tax a few years ago – to see the consequences may not be intended. It raised the price of a wide range of products and put small businesses such as grocers selling cheese particularly at risk. Consumers found ways to circumvent the tax, for example by buying products in Germany.
In January the British Medical Journal reported research from Mexico which suggested that its 10% sales tax on sweetened drinks had resulted in something like a 12% reduction in sales. But beware of direct comparisons: this was a simple sales tax passed on to consumers in a country where food accounts for a larger proportion of a person’s income than in the UK.
In contrast, the UK version looks like being levied on the manufacturers. The problem is that they can avoid being penalised if they pass on the cost to consumers – assuming it’s not enough to make consumers choose different products. On the other hand if the companies do absorb the cost, what difference will it have to the obesity and other health issues caused by too much sugar? The companies pay a bit more tax and consumers still get their sugar fix.
Ultimately I do not think we will see the behaviour change that some hope for from this one tax, especially as there are so many other products with just too much sugar and above all too many calories on the market. As I have said before, what we need is for companies to reformulate their products. All we can hope for is that this might be a nudge in the right direction.
Isabelle Szmigin does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond the academic appointment above.
Isabelle Szmigin, Professor of Marketing, University of Birmingham
This article was originally published on The Conversation. Read the original article.



Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Why the future of marijuana legalization remains hazy despite high public support
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
The four types of dementia most people don’t know exist
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 



